Andrew Brooks (1969–2021), scientist who developed first COVID-19 spit test
Reading now: 892
legacy.comAndrew Brooks was a research professor at Rutgers University and CEO of Infinity Biologix, who developed the first FDA-approved rapid saliva test for COVID-19.Brooks joined the faculty at Rutgers in 2004, and in 2009, he began working at the university’s Cell and DNA Repository.
The company later went private, renamed Infinity Biologix, with Brooks at its helm. As the COVID-19 pandemic gripped the U.S.
in 2020, Brooks began leading the company’s effort to develop a saliva test. This test is able to produce faster results than a nasal or throat swab, without requiring a health worker to closely approach a potentially infected person to take a sample.
Read more on legacy.com
The website celebsbar.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
